Back to Search

Dose-Finding Trial to Evaluate the Safety and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647 in Healthy Adults

Oklahoma City, Oklahoma, 73112
Hadar, Nebraska, 68701
Shawnee, Kansas, 66219
Lakeside, Texas, 76135
Victoria, Texas, 77901
Search open until 05/30/2022

This clinical study will assess the safety and immunogenicity of 3 dose levels of mRNA-1647 cytomegalovirus vaccine in CMV-seronegative and CMV-seropositive healthy adults 18-40 years of age.

Eligibility

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, learn about Clinical

Ages Eligible for Study Min Age: 18 years - Max Age: 40 years
Sexes Eligible for Study All
Accepts Healthy Volunteers No

Visit ClinicalTrials.Gov for more information
Support nonprofit organizations through participating in clinical trials at no cost to you
You may also be interested in
New Orleans, Louisiana and more
Evaluation of ADG20 for the Prevention of COVID-19
COVID-19 Read more
Oklahoma City, Oklahoma and more
Dose-Finding Trial to Evaluate the Safety and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647 in Healthy Adults
Cytomegalovirus Infection Read more
Culver City, California
A Home-based Study Using Mobile Technology to Test Whether BI 1358894 is Effective in People With Depression
Major Depressive Disorder Read more